BioNotebook: Seven deals and updates, including 190 pre-merger layoffs at Auxilium
This article was originally published in Scrip
Executive Summary
Auxilium cutting 190 jobs ahead of QLT merger; Cempra gets $10m milestone payment; Ligand, CURx sign license deal; Telik will soon be MabVax after merger; Ophthotech earns $50m fee from Novartis; Momenta exercises option with AnaptysBio; and J&J initiates neuroscience collaboration.